Radiofrequency ablation, also called rhizotomy, is a nonsurgical, minimally invasive procedure that uses heat to reduce or stop the transmission of pain. Radiofrequency waves ablate, or "burn," the nerve that is causing the pain, essentially eliminating the transmission of pain signals to the brain.
This procedure is most commonly used to treat chronic pain and conditions such as arthritis of the spine (spondylosis) and sacroilitis. It is also used to treat neck, back, knee, pelvic and peripheral nerve pain. The benefits of radiofrequency ablation include avoiding surgery, immediate pain relief, little to no recovery time, decreased need for pain medication, improved function, and a quicker return to work and other activities.
A radiofrequency ablation is a minimally invasive procedure that destroys the nerve fibers carrying pain signals to the brain. It can provide lasting relief for people with chronic pain, especially in the lower back, neck and arthritic joints.Based on product type, the radiofrequency ablation for pain management market has been segmented into RF generators, reusable (probes, electrodes), and disposable (cannula, needles, single-use probes, and single-use electrodes). Of these, the segment of disposable products, accounted for over 43.9% of the global market in 2019.Radiofrequency Ablation for Pain Management is widely sold in Hospital, Clinic. The most proportion of Radiofrequency Ablation for Pain Management is sold in Hospital, and the proportion in 2019 is 66.9%.
North America is the largest Sales place, with a Sales market share nearly 48.3% in 2019. Following North America, Europe is the second largest Sales place with the Sales market share of 24.2%.
Market competition is intense. Abbott (St. Jude Medical), Avanos Medical, Stryker, Boston Scientific, etc.
Market Analysis and Insights: Global Radiofrequency Ablation for Pain Management Market
The global Radiofrequency Ablation for Pain Management market size is projected to reach US$ 487.1 million by 2027, from US$ 249.8 million in 2020, at a CAGR of 10.0% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Radiofrequency Ablation for Pain Management market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Radiofrequency Ablation for Pain Management market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Radiofrequency Ablation for Pain Management market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Radiofrequency Ablation for Pain Management market.
Global Radiofrequency Ablation for Pain Management Scope and Market Size
Radiofrequency Ablation for Pain Management market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Radiofrequency Ablation for Pain Management market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Segment by Application
Rest of Europe
Rest of Asia
Rest of Latin America
Middle East & Africa
Rest of MEA
Abbott (St. Jude Medical)
Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region